Publicação
Drug targeting of inflammatory bowel diseases by biomolecules
| Resumo: | Inflammatory bowel disease (IBD) is a group of disabling, destructive and incurable immune-mediated inflammatory diseases comprising Crohn's disease (CD) and ulcerative colitis (UC), disorders that are highly prevalent worldwide and demand a large investment in healthcare. A persistent inflammatory state enables the dysfunction and destruction of healthy tissue, hindering the initiation and endurance of wound healing. Current treatments are ineffective at counteracting disease progression. Further, increased risk of serious side effects, other comorbidities and/or opportunistic infections highlight the need for effective treatment options. Gut microbiota, the key to preserving a healthy state, may, alternatively, increase a patient's susceptibility to IBD onset and development given a relevant bacterial dysbiosis. Hence, the main goal of this review is to showcase the main conventional and emerging therapies for IBD, including microbiota-inspired untargeted and targeted approaches (such as phage therapy) to infection control. Special recognition is given to existing targeted strategies with biologics (via monoclonal antibodies, small molecules and nucleic acids) and stimuli-responsive (pH-, enzyme- and reactive oxygen species-triggered release), polymer-based nanomedicine that is specifically directed towards the regulation of inflammation overload (with some nanosystems additionally functionalized with carbohydrates or peptides directed towards M1-macrophages). The overall goal is to restore gut balance and decrease IBD's societal impact. |
|---|---|
| Autores principais: | Antunes, Joana Isabel Costa |
| Outros Autores: | Seabra, Catarina Leal; Domingues, Joana Margarida; Teixeira, Marta Oliveira; Nunes, Cláudia; Costa-Lima, Sofia Antunes; Homem, Natália Cândido; Reis, Salette; Amorim, M. T. Pessoa de; Felgueiras, Helena Prado |
| Assunto: | Biologics Gut dysbiosis Infection Microbiota Crohn’s disease Ulcerative colitis Treatment Polymeric nanoparticles |
| Ano: | 2021 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade do Minho |
| Idioma: | inglês |
| Origem: | RepositóriUM - Universidade do Minho |
Registos relacionados
school Microbiota e doença inflamatória intestinal
por: Malaquias, Catarina Silva
Publicado em: (2019)
por: Malaquias, Catarina Silva
Publicado em: (2019)
groups New pharmacological approach for inflammatory bowel disease
por: Silva, Inês
Publicado em: (2019)
por: Silva, Inês
Publicado em: (2019)
article The histopathological approach to inflammatory bowel disease: a practice guide
por: Langner, C.
Publicado em: (2014)
por: Langner, C.
Publicado em: (2014)
article Crossing barriers: the burden of inflammatory bowel disease across Western Europe
por: Kumar, Aditi
Publicado em: (2023)
por: Kumar, Aditi
Publicado em: (2023)
article Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese survey
por: Revés, Joana Branco
Publicado em: (2021)
por: Revés, Joana Branco
Publicado em: (2021)
groups Preliminary study towards a chronic experimental model to study inflammatory bowel disease
por: Silva, Inês
Publicado em: (2020)
por: Silva, Inês
Publicado em: (2020)
school Preliminary study towards a novel chronic experimental model to study Inflammatory bowel disease
por: Modesto, Rita Eusébio
Publicado em: (2019)
por: Modesto, Rita Eusébio
Publicado em: (2019)
article Treatment of inflammatory bowel disease: is your patient at risk of non-adherence?
por: Magalhães, Joana
Publicado em: (2014)
por: Magalhães, Joana
Publicado em: (2014)
article Sexual quality of life in inflammatory bowel disease: A multicenter, national-level study
por: Roseira, Joana
Publicado em: (2020)
por: Roseira, Joana
Publicado em: (2020)
article Mesalazine and inflammatory bowel disease from well-established therapies to progress beyond the state of the art
por: Veloso, Pedro
Publicado em: (2021)
por: Veloso, Pedro
Publicado em: (2021)
article Neurology of inflammatory bowel disease
por: Ferro, José
Publicado em: (2021)
por: Ferro, José
Publicado em: (2021)
school The microbiome of inflammatory bowel disease
por: Duarte, Marta Teresa Marques
Publicado em: (2022)
por: Duarte, Marta Teresa Marques
Publicado em: (2022)
article Quality of life in patients with inflammatory bowel disease: importance of clinical, demographic and psychosocial factors
por: Magalhães, Joana
Publicado em: (2014)
por: Magalhães, Joana
Publicado em: (2014)
groups Preliminary results of an animal model validation of chronic experimental colitis
por: Silva, Inês
Publicado em: (2020)
por: Silva, Inês
Publicado em: (2020)
article Clinical significance of histologic healing in IBD: evidence from randomized controlled trials (RCT) and real world (RW) data
por: Estevinho, Maria Manuela
Publicado em: (2025)
por: Estevinho, Maria Manuela
Publicado em: (2025)
groups TNBS-induced colitis in rodents: preliminary results of a chronic model
por: Silva, Inês
Publicado em: (2019)
por: Silva, Inês
Publicado em: (2019)
article Let’s review the gut microbiota in systemic lupus erythematosus
por: Almada-Correia, Inês
Publicado em: (2022)
por: Almada-Correia, Inês
Publicado em: (2022)
school Phenotypes in inflammatory bowel disease
por: Torres, Joana Maria Tinoco da Silva
Publicado em: (2018)
por: Torres, Joana Maria Tinoco da Silva
Publicado em: (2018)
article Managing IBD patients with concomitant HIV infection : a systematic review
por: Sousa, Hugo
Publicado em: (2024)
por: Sousa, Hugo
Publicado em: (2024)
article Tailoring gut microbiota with a combination of vitamin K and probiotics as a possible adjuvant in the treatment of rheumatic arthritis: a systematic review
por: Pereira, Luciana
Publicado em: (2022)
por: Pereira, Luciana
Publicado em: (2022)
school Bacteriófagos e a microbiota intestinal
por: Leandro, Luis Miguel Peralta
Publicado em: (2022)
por: Leandro, Luis Miguel Peralta
Publicado em: (2022)
category Isotretinoin and inflammatory bowel disease
por: Rolanda, Carla
Publicado em: (2007)
por: Rolanda, Carla
Publicado em: (2007)
book Next-generation probiotics
por: Barbosa, Joana Cristina
Publicado em: (2021)
por: Barbosa, Joana Cristina
Publicado em: (2021)
school Impact of maternal obesity on early-life microbiota-induced immune system priming
por: Magalhães, Maria Inês Martins Santos de
Publicado em: (2023)
por: Magalhães, Maria Inês Martins Santos de
Publicado em: (2023)
article Primary humoral immune deficiencies: overlooked mimickers of chronic immune-mediated gastrointestinal diseases in adults
por: Malesza, Ida Judyta
Publicado em: (2020)
por: Malesza, Ida Judyta
Publicado em: (2020)
article Extracellular vesicles from nanomedicine-trained intestinal microbiota substitute for fecal microbiota transplant in treating Ulcerative Colitis
por: Zu, Menghang
Publicado em: (2024)
por: Zu, Menghang
Publicado em: (2024)
article Preclinical study in vivo for new pharmacological approaches in inflammatory bowel disease: a systematic review of chronic model of TNBS-induced colitis
por: Silva, Inês
Publicado em: (2019)
por: Silva, Inês
Publicado em: (2019)
article Clinical performance of an infliximab rapid quantification assay
por: Magro, Fernando
Publicado em: (2017)
por: Magro, Fernando
Publicado em: (2017)
article Mechanisms leading to gut dysbiosis in COVID-19: current evidence and uncertainties based on adverse outcome pathways
por: Clerbaux, Laure Alix
Publicado em: (2022)
por: Clerbaux, Laure Alix
Publicado em: (2022)
school The Microbiome-gut-brain axis and its influence on neurodegenerative diseases: focus on Alzheimer's Disease
por: Ettenberger, Denise
Publicado em: (2024)
por: Ettenberger, Denise
Publicado em: (2024)
science miR-21-5p dysregulation is associated with gut microbiota dysbiosis and pro-oncogenic markers in primary sclerosing cholangitis with concomitant inflammatory bowel disease
por: Santos, André Anastácio
Publicado em: (2026)
por: Santos, André Anastácio
Publicado em: (2026)
article In vitro models as a tool to study the role of gut microbiota in obesity
por: Colunga, Alondra
Publicado em: (2024)
por: Colunga, Alondra
Publicado em: (2024)
article Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays
por: Afonso, Joana
Publicado em: (2017)
por: Afonso, Joana
Publicado em: (2017)
article Intake of nanoparticles and impact on gut microbiota: in vitro and animal models available for testing
por: Campos, Débora
Publicado em: (2022)
por: Campos, Débora
Publicado em: (2022)
article Efficacy and safety of erythropoietin in a chronic model of inflammatory bowel disease
por: Silva, Inês
Publicado em: (2022)
por: Silva, Inês
Publicado em: (2022)
article Hemin ameliorates the inflammatory activity in the inflammatory bowel disease: a non-clinical study in rodents
por: Silva, Inês
Publicado em: (2022)
por: Silva, Inês
Publicado em: (2022)
article Effect of Cynara cardunculus L. var. altilis (DC) in inflammatory bowel disease
por: Mateus, Vanessa
Publicado em: (2021)
por: Mateus, Vanessa
Publicado em: (2021)
school Oral health and the microbiome dysbiosis in inflammatory bowel disease
por: Cardoso, Catarina Pereira
Publicado em: (2025)
por: Cardoso, Catarina Pereira
Publicado em: (2025)
article Essential role of small bowel capsule endoscopy in reclassification of colonic inflammatory bowel disease type unclassified
por: Monteiro, Sara
Publicado em: (2017)
por: Monteiro, Sara
Publicado em: (2017)
article Chronic experimental model of TNBS-induced colitis to study inflammatory bowel disease
por: Silva, Inês
Publicado em: (2022)
por: Silva, Inês
Publicado em: (2022)
Registos relacionados
-
school Microbiota e doença inflamatória intestinal
por: Malaquias, Catarina Silva
Publicado em: (2019) -
groups New pharmacological approach for inflammatory bowel disease
por: Silva, Inês
Publicado em: (2019) -
article The histopathological approach to inflammatory bowel disease: a practice guide
por: Langner, C.
Publicado em: (2014) -
article Crossing barriers: the burden of inflammatory bowel disease across Western Europe
por: Kumar, Aditi
Publicado em: (2023) -
article Inflammatory Bowel Disease patients’ perspectives during COVID-19 pandemic: results from a Portuguese survey
por: Revés, Joana Branco
Publicado em: (2021)